BioPerfectus Introduces New Nucleic Acid Extraction Solution
BioPerfectus is proud to announce the release of three new products: Nucleic Acid Extraction System SSNP-A6 (FDA-listed), Nucleic Acid Extraction Rapid Kit 96T (Magnetic Bead Method) and Nucleic Acid Extraction and Purification Rapid Kit 96T.
Respiratory Panel Kits for Efficient Syndromic Testing
BioPerfectus Respiratory Panel Kits are Real-Time PCR tests that detect 16 pathogens associated with similar and overlapping clinical symptomatology, enabling better patient management.
BioPerfectus Launches SAW-48 and Cell Nucleic Acid Extraction Kit
BioPerfectus is proud to announce the launch of two new products, which obtained FDA and CE certification: Automated Nucleic Acid Extraction Workstation SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method). These products are designed to automate STD and HPV detection.
BioPerfectus GI Total PCR Solution is preparing for norovirus detection
BioPerfectus is pleased to launch Norovirus Real Time PCR Kit and Norovirus GI and GII Real Time PCR Kit to safeguard our children with high clinical performance.
Zoonotic Infectious Diseases Total PCR Solution
BioPerfectus proudly introduce 13 new members to our Zoonotic Infectious Diseases Total PCR Solution, offering verified products and prompt responses to global health emergencies.
Cervical Cancer Screening Solution
With over 600 thousand new cases and more than half that would lead to death yearly, cervical cancer is listed as NO.4 cancer among women worldwide. Lack of screening and treatment leads to higher rates of incidence and mortality. Bioperfectus is confident in providing products, supporting tests for cervical swabs, and liquid-based cytology samples with solid results, enabling women to get access to screening and diagnosis at the early stage of HPV infection before the development of precancerous lesions and cervical cancer.
Monkeypox Virus Diagnostic Solution
With increasing confirmed monkeypox cases, more people, countries, and regions are at risk of infection. Nowadays, confirmed cases of infants and cases in schools have been reported; the monkeypox virus has spread among vulnerable individuals, indicating great urgent demand for early diagnosis. Bioperfectus provides FIVE kits for humans with a CE certificate and ONE kit for veterinary use, presenting a rapid response to help diagnose monkeypox infection as early as possible.
SAW-96 is an automated nucleic acid extraction workstation, which integrates sample loading, nucleic acid purification, and PCR setup functions in one instrument. The run duration is less than 70 minutes for 1-96 samples. Based on experienced magnetic separation technology, SAW-96 provides high throughput automation combined with high performance.
Total PCR Solution
Bioperfectus Total PCR Solution offers holistic products of extraction systems, extraction reagents, real-time PCR systems, and RT-PCR reagents. The automatic solution could help customers to establish a highly efficient PCR workflow and release the labor.

Jiangsu Bioperfectus Technologies Co., Ltd.


Since its founding in 2010, BioPerfectus has been dedicated to providing molecular diagnostic solutions specializing in emerging infectious diseases for generations and generations to come. We are leading the change by offering Real-Time PCR Kits, Nucleic Acid Extraction Systems, Automation Solutions, and Rapid Tests to laboratories, hospitals, institutions, and CDCs across the globe. BioPerfectus products have been distributed to more than 100 countries around the world. As one of the leading global IVD suppliers, BioPerfectus is committed to delivering excellent services and products that meet the highest international quality and safety standards. Our global presence enables us to build close relationships with our clients and leverage our expertise to support them worldwide.

62,000 +㎡

An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios

800 +

Over 800 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic

5,000,000 +

Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases

global presence

90 Countries within a year

Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.

20000 Installation base

Bioperfectus Nucleic Acid Extraction Solutions
were launched in over 20,000 laboratories
globally with a well-trained and quick-response
customer service team.

Product Center
News Center
Celebrating Three Years of International Growth and Success at BioPerfectus
Celebrating Three Years of International Growth and Success at BioPerfectus
Today, we spotlight the remarkable journey of BioPerfectus's global footprint, a testament to our significant growth and expansion. Our unwavering commitment to global health has been the guiding force, reinforcing our mission, "BioPerfectus, for a healthier future". Our international strategy has been pivotal in our success, with the establishment of subsidiaries in strategic locations such as the United States, Hong Kong, and the United Kingdom. This strategic expansion has enabled us to cater to various markets and meet our customers' diverse needs more effectively. In times of global health crises, BioPerfectus has played a crucial role, contributing significantly to the fight against major pandemics such as COVID-19, Monkeypox, and Ebola. Our unwavering commitment and demonstrated responsibility during these critical periods are sources of immense pride. The dedicated efforts of our partners and employees have significantly contributed to our success story. Their experiences and collaborations have fostered strong relationships and driven the mutual growth that is at the heart of BioPerfectus's global footprint. As we acknowledge our achievements, we also envision a future brimming with opportunities. Our CEO, Dr. Guoqiang Wang, provides a clear vision for BioPerfectus's future and our ongoing development plans. His inspiring words motivate our team and partners to rise above challenges and achieve more. In recognition of this significant journey, we express our deepest gratitude to our dedicated team and partners. Your commitment and passion have turned our shared vision into reality, and for that, we say, "Thank you!" We move forward with an unwavering commitment to our mission, ready to seize the opportunities of tomorrow. As we continue to acknowledge our past successes and eagerly anticipate a future full of growth, innovation, and contribution to global health, we affirm our unity as BioPerfectus. Together, let's forge ahead towards a healthier future!
BioPerfectus Launches New PCR Kit for STD Diagnostic Solution
BioPerfectus Launches New PCR Kit for STD Diagnostic Solution
SHANGHAI, CHINA, April 27, 2023Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as BioPerfectus) announces the CE marking of one new product:Herpes Simplex Virus Type I/II Real Time PCR Kit. Combined with ourAutomated Nucleic Acid Extraction WorkstationandReal Time PCR System, we could provide a STD total PCR solution for the early detection of sexually transmitted diseases which affect many people. Herpes simplex virus (HSV), a common infection that can cause painful blisters or ulcers, is widespread among humans globally. It primarily spreads by skin-to-skin contact. The infection is lifelong and characterized by periodic reactivations at the infection site. Globally, more than 500 million people have genital herpes simplex virus infection. An estimated 3.7 billion people under age 50 (67%) have herpes simplex virus type 1 (HSV-1) infection, the main cause of oral herpes and 491 million people aged 1549 (13%) have herpes simplex virus type 2 (HSV-2) infection, the main cause of genital herpes. The overall rate of neonatal herpes was estimated to be about ten cases per 100 000 live births, equivalent to a best estimate of 14 000 cases annually roughly (4000 for HSV-1; 10 000 for HSV-2). Fig. Map of regional estimates of the number and prevalence of herpes simplex virus type 2 infections in females and males, 2016 In order to better deal with this global burden, the World Health Assembly adopted the Global Health Sector Strategy on Sexually Transmitted Infections, 20162021, which aims to end sexually transmitted infections as a public health concern by 2030, focusing on vastly scale up primary prevention and increase access to screening for sexually transmitted infections. As for herpes simplex virus, which is highly contagious and can be transmitted via any type of physical contact, early and accurate detection is needed to prevent the transmission. Whats worse, genital herpes can cause painful genital sores and can be severe in people with suppressed immune systems if left without treatment. As a pioneer in molecular diagnostics, BioPerfectus remains dedicated to developing new diagnostic solutions, working diligently to offer a comprehensive range of STI panels. By offering a comprehensive STD diagnostic solution, BioPerfectus is committed to aiding in the early-stage screening and diagnosis of various sexually transmitted infections, ensuring accurate detection to prevent severe outcomes. Reference: - - -James, Charlotte et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016.Bulletin of the World Health Organizationvol. 98,5 (2020): 315-329. doi:10.2471/BLT.19.237149 -Looker, Katharine J et al. First estimates of the global and regional incidence of neonatal herpes infection.The Lancet. Global healthvol. 5,3 (2017): e300-e309. doi:10.1016/S2214-109X(16)30362-X
BioPerfectus Launches SSNP-A6, Nucleic Acid Extraction Rapid Kit 96T and Nucleic Acid Extraction and Purification Rapid Kit 96T
BioPerfectus Launches SSNP-A6, Nucleic Acid Extraction Rapid Kit 96T and Nucleic Acid Extraction and Purification Rapid Kit 96T
SHANGHAI, CHINA, April 26th, 2023Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as "BioPerfectus") is proud to announce the release of three new products: Nucleic Acid Extraction System SSNP-A6 (FDA-listed,CE-IVDR), Nucleic Acid Extraction Rapid Kit 96T (Magnetic Bead Method) (CE-IVDR) and Nucleic Acid Extraction and Purification Rapid Kit 96T (CE-IVDR ). Designed for high efficiency and continuous high throughput, these products offer a rapid and automated solution for the extraction of nucleic acids. SSNP-A6 is an in vitro diagnostic medical device, which integrates cutting-edge mechanical, electronic and software technologies. Compatible with Nucleic Acid Extraction Rapid Kit 96T (Magnetic Bead Method), SSNP-A6 enables automated extraction of nucleic acids from samples such as nasopharyngeal swab, pharyngeal swab, nasal swab, serum, plasma, urine, cervical swab, urethral swab, etc. Meanwhile, SSNP-A6 can extract nucleic acids from 96 samples simultaneously to meet the requirement for high throughput. Nucleic Acid Extraction and Purification Rapid Kit 96T is designed to work with the KingFisher Flex, KingFisher Apex, and other fully automated nucleic acid extraction systems produced by Thermo Fisher Scientific. It can efficiently extract from samples such as nasopharyngeal swab, pharyngeal swab, nasal swab, serum, plasma, urine, cervical swab, urethral swab, etc. As a company dedicated to addressing the health challenges faced by humanity, BioPerfectus continues to embrace innovation and pursue excellence in the field of molecular diagnostics.
Service Network
Support is only one step away
A good after-sales service is essential for efficiency of workload in PCR laboratory. Bioperfectus delivers most perfect service via our authorized distributors and global service center. With well-experienced service staff, sufficient spare-part inventory and fast global logistics, Bioperfectus aims to provide with the satisfactory solutions to our end users.We offer 24/7 after-sales service, prompt response and periodical training programs.